Cross-Sector entity

xAI

Company
5.9

xAI is most often covered alongside Elon Musk, which appears in 14 of these 20 stories. The 28-day window averages about 5 stories each week. The busiest single day carried 4. The clearest coverage concentration is regulation: 4 of 20 stories, with the rest divided among 11 other categories.

251 verified stories tracked

Last mentioned: Aug 12, 2026

Entity pulse

Recent coverage · xAI

20 stories
5.9 avg impact
15% positive
40% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 25 percentage points.

  • 15% positive
  • 45% neutral
  • 40% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about xAI

xAI is most often covered alongside Elon Musk, which appears in 14 of these 20 stories. The 28-day window averages about 5 stories each week. The busiest single day carried 4. The clearest coverage concentration is regulation: 4 of 20 stories, with the rest divided among 11 other categories. We currently track 20 Cross-Sector stories that mention xAI, published between July 16, 2026 and August 12, 2026. Negative sentiment appears in 40% of the tracked stories. Each carries 2.1 original sources on average.

Stories tracked
20
Per week
5
Negative
40%
Sources per story
2.1

Computed from the 20 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering xAI. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Demand Milestone

    Projected date for U.S. energy demand to triple due to AI and industrial growth.

  2. Energy Demand Forecast

    Projected date for U.S. energy demand to triple due to AI and data center growth.

  3. Projected Supply Ceiling

    The estimated timeframe when external foundry capacity is expected to fail Tesla's volume requirements.

  4. Projected Scale

    Target window for Terafab to meet the volume needs of millions of Optimus robots.

  5. Mass Production

    Target date for full-scale 2nm wafer manufacturing.

  6. Early Production

    Initial chip fabrication begins at the Austin facility.

  7. Scaling Operations

    Estimated window for scaling to full-size fabrication and high-volume output.

  8. Targeted IPO Window

    SpaceX eyes a massive public offering to capitalize on its new AI-integrated valuation.

  9. Growth Target

    Target date for reaching a total headcount of 8,000 employees.

  10. Anticipated SpaceX IPO

    SpaceX expected to go public following the integration of xAI and orbital data center push.

  11. Targeted IPO Window

    SpaceX targets a late 2026 date for what could be the largest IPO in history.

  12. Target IPO Window

    Projected date for the SpaceX public offering following the merger integration.

  13. Merger Completion

    Expected finalization of the merger between xAI and SpaceX.

  14. Anticipated SpaceX IPO

    SpaceX prepares for a landmark initial public offering following balance sheet cleanup.

  15. Target IPO

    SpaceX begins formal preparations for a potential historic public offering.

  16. Groundbreaking

    Anticipated start of construction for the Advanced Technology Fab in Austin.

  17. FCC Filing

    SpaceX files for a 1-million satellite orbital data center constellation.

  18. Prototype Facility

    Planned construction of a 'mini' fab for initial testing and 2nm process validation.

  19. Phase-out Deadline

    Scheduled completion date for the removal of all Anthropic tools from DoD systems.

  20. Insider lockup expiration begins

    Two trading days after the earnings release, up to 20% of eligible insider and employee shares become free to trade, creating a potential sell pressure event.

Stories mentioning xAI 20

Biotech clinical trial Neutral 5

Neuralink’s future in Musk’s $2.1T empire hinges on brain implant progress

While SpaceX’s record IPO captures headlines, Neuralink remains Musk’s most medically transformative—and least proven—venture. Brain-computer interface technology could revolutionize treatment for neurological disorders, but faces immense regulatory, clinical, and funding challenges. The empire’s financial coherence may dictate how fast this biotech moonshot advances.

2 sources

Source: economictimes.indiatimes.com · timesfreepress.com

PropTech commercial real estate Neutral 5

Multi-Million-Dollar Tax Windfall? Data Center Task Force Eyes Great Falls Boom

Great Falls, Montana, is weighing large-scale data center development that could generate significant property tax revenue and construction jobs, guided by a public task force and a new state-level pledge that shields ratepayers from energy costs. The outcome could reshape commercial real estate valuations and land use in the region.

AI funding Neutral 5

Nasdaq AI Rebound Pushes Up 1.1% as $28B SK Hynix IPO Looms

AI stocks staged a sharp recovery on Monday, with the Nasdaq rising 1.1% as Broadcom rallied on an Apple deal. The rebound comes just days before SK Hynix's historic $28 billion Nasdaq IPO, which will be the latest test of investor appetite for AI infrastructure.

2 sources
Startups acquisition Negative 6

How a $2.8T startup lost its M&A window: SpaceX’s dilution lesson

SpaceX’s post-IPO stock volatility offers a stark masterclass for startup founders: even the world’s most valuable private company can see its acquisition currency evaporate in days. The 34-percentage-point jump in dilution shows why timing M&A around stock peaks is both an art and a science, and why locked-in valuations are vital. For founders eyeing strategic acquisitions, the SpaceX story underscores the peril of assuming today’s high-flying stock will be tomorrow’s currency.

2 sources
Space & Defense acquisition Negative 6

SpaceX’s $2.8T peak fades: Tesla merger dilution now 91% as window closes

SpaceX’s chance to buy Tesla using its soaring post-IPO stock may have vanished, with the dilution ratio nearly doubling as the rocket maker’s shares fell and Tesla surged. For the space industry, a merger would create a powerhouse that integrates Starlink, Grok AI, and advanced robotics into a single entity, but the timing now looks far more painful for SpaceX shareholders.

2 sources
Finance markets Negative 6

SpaceX-Tesla deal math turns toxic: Dilution jumps from 57% to 91% in one week

For investors, the relative valuation shift between SpaceX and Tesla in late July 2026 has dramatically worsened the economics of a potential acquisition. The dilution that SpaceX shareholders would face nearly doubled as the acquirer’s stock fell and the target’s rose, turning what looked like a clever use of rich stock into an equity nightmare. The episode is a stark reminder that even the most visionary founders cannot time markets perfectly.

2 sources

Source: fortune.com · finance.yahoo.com

Startups funding Positive 8

Enigma Raises $71M Seed Round to Democratize Robot Intelligence

Physical AI startup Enigma raised a massive $71M seed round led by Index Ventures and Ribbit Capital, emerging from stealth with a live public demo of AI-powered robots. Co-founded by a Microsoft prodigy, the company aims to build a universal intelligence layer for any robot, signaling sky-high investor appetite for robotics infrastructure.

2 sources
Legal court decisions Negative 6

xAI Sues User Over CSAM Deepfakes: 244 Arrests Follow 52K Account Bans in 2026

xAI’s landmark lawsuit against a Grok user for generating CSAM and non-consensual deepfakes tests platform liability and terms-of-service enforcement. With 52,222 account suspensions and 244 arrests in 2026, the case may set a precedent for holding users civilly liable for AI-generated exploitation.

2 sources